Literature DB >> 11990409

Methodological issues in assessing the incidence of peritoneal dialysis-associated peritonitis in children.

Franz Schaefer1, Marianne Kandert, Reinhard Feneberg.   

Abstract

OBJECTIVES: To evaluate the distribution of peritonitis incidence and assess the usefulness of patient-specific peritonitis rates in children.
DESIGN: 49 children on automated peritoneal dialysis (PD) followed during a 2-year observation period.
SETTING: Single-center, academic children's hospital. PATIENTS: 49 children aged 2 months to 18 years; 24 prevalent, 25 incident during the observation period. Cumulative observation time was 639 patient-months. MAIN OUTCOME MEASURES: Cohort-specific peritonitis incidence, median patient-specific peritonitis incidence, mean peritonitis incidence by gamma-Poisson (negative binomial) modeling, peritonitis-free survival by Kaplan-Meier life-table analysis.
RESULTS: 68 new peritonitis episodes and 21 relapses occurred in 27 patients. The distribution of patient-specific peritonitis incidence was bimodal, with a large group experiencing no or very few episodes, and another cluster around 1 episode per 6-9 months. Overall cohort-specific peritonitis incidence was 1.28, median subject-specific incidence 0.99, and mean incidence according to negative binomial modeling 1.04 (95% confidence interval 1.02-1.06) episodes per patient-year. Median peritonitis-free survival time was 6.9 months. In those patients who developed peritonitis, subject-specific peritonitis incidence was inversely correlated with patient age (r = -0.42, p < 0.05) and duration of chronic PD at last observation (r = -0.42, p < 0.05).
CONCLUSIONS: Since the distribution of peritonitis in children is non-Gaussian, the average risk of peritonitis is more accurately expressed by the median of the individual subject-specific peritonitis rates or by the mean incidence estimate obtained by the negative binomial distribution model. The assignment of a personal peritonitis risk to each patient permits risk factor analysis by routine statistical methods, even in smaller populations.

Entities:  

Mesh:

Year:  2002        PMID: 11990409

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  7 in total

Review 1.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

Review 2.  Management of peritonitis in children receiving chronic peritoneal dialysis.

Authors:  Franz Schaefer
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 3.  New insights on preventing and managing peritonitis.

Authors:  Beth Piraino
Journal:  Pediatr Nephrol       Date:  2003-12-10       Impact factor: 3.714

4.  Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database.

Authors:  Sharon J Nessim; Joanne M Bargman; Peter C Austin; Rosane Nisenbaum; Sarbjit V Jassal
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 8.237

Review 5.  Dialysis-associated peritonitis in children.

Authors:  Vimal Chadha; Franz S Schaefer; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2009-02-04       Impact factor: 3.714

6.  Modelling competing risks in nephrology research: an example in peritoneal dialysis.

Authors:  Laetitia Teixeira; Anabela Rodrigues; Maria J Carvalho; António Cabrita; Denisa Mendonça
Journal:  BMC Nephrol       Date:  2013-05-24       Impact factor: 2.388

Review 7.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.